Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00031889

  • | Pays :
  • Switzerland
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using exemestane plus bicalutamide may fight prostate cancer by reducing the production of androgens. It is not yet known if exemestane is more effective with or without bicalutamide in treating prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of exemestane with or without bicalutamide in treating patients who have stage IV prostate cancer that has been previously treated with hormone therapy or surgery.


Critère d'inclusion

  • Prostate cancer

Liens